We previously reported the presence of a basement membrane-specific chondroitin sulfate proteoglycan (BM-CSPG) in basement membranes of almost all adult tissues. However, an exception to this ubiquitous distribution was found in the kidney, where BM-CSPG was absent from the glomerular capillary basement membrane (GBM) but present in other basement membranes of the nephron, including collecting ducts, tubules, Bowman's capsule, and the glomerular mesangium. In light of this unique pattern of distribution and of the complex histoarchitectural reorganization occurring during nephrogenesis, the present study used light and electron microscopic immunohistochemistry to examine the distribution of BM-CSPG and basement membrane heparan sulfate proteoglycan (BM-HSPG) during prenatal and postnatal renal development in the rat. Our results show that the temporal and spatial pattern of expression of BM-CSPG during nephrogenesis is unlike that reported for other basement membrane components such as laminin, fibronectin, and BM-HSPG, all of which can be found in the earliest formed basement membranes of the vesicle-stage nephron. Although BM-CSPG is present in the 402 McCARTHY, BYNUM, ST. JOHN, ABRAHAMSON, COUCHMAN PROTEOGLYCANS IN RENAL DEVELOPMENT 403
Introduction
Basement membranes are complex extracellular matrices present at epitheliaUmesenchymal interfaces and surrounding muscle, nerve, and fat cells. Rather than being an amorphous boundary layer in tissues as was described by early histologists, basement membranes are now understood to be a polyprotein composite, with the physicochemical properties of each component thought to impart spe-Supported by grant ALG-90007 from the Alabama Affiliate of the American Heart Association (KJM). and by National Institutes of Health grants 5T32HL07457, AR36457 URC) and DK34972 (DRA). JRC is an Established Investigator of the American Heart Association.
Correspondence to: K. J. McCarthy, PhD, Dept. of Cell Biology, Rm. 220, Volker Hall, VH 803, Univ. of Alabama at Birmingham, Birmingham, AL 35294. basement membranes of the invading vasculature and ureteric buds, its first appearance in nephron basement membrane occurs during the late comma stage. In capillary loopstage glomeruli of prenatal animals, BM-CSPG is present in the presumptive mesangial matrix but undetectable in the GBM. However, as postnatal glomerular maturation progresses BM-CSPG is also found in both the lamina rara interna and lamina densa of the GBM in progressively increasing amounts, being most evident in the GBM of 21day-old animals. Micrographs of glomeruli from 42-day-old animals show that BM-CSPG gradually disappears from the GBM and, by 56 days after birth, appears to be completely absent from the GBM, its pattern of distribution resembling that of the adult animal. Our results show that BM-CSPG is not required for the initial assembly of basement membranes but may in fact serve to stabilize basement membrane structure after histoarchitectural reorganization is completed. (J Histochem Cytochem 41:401414, 1993) cific functional qualities such as control of macromolecular filtration (18), cell migration and differentiation (33) , and binding of growth factors (24, 45, 54) . The discovery of the Englebreth-Holm-Swarm tumor (EHS) as an abundant source of material led to the acceleration of the transition of basement membrane research from histochemical to biochemical and molecular analysis. As a result, early basement membrane biochemists, using the composition of EHS tumor basement membrane as a benchmark, suggested that basement membranes exist in every tissue as a composite with defined stoichiometry, consisting of the proteins laminin, entactinhidogen, Type IV collagen, and heparan sulfate proteoglycan (34, 52, 53) . However, recent studies using combined biochemistry and immunochemical approaches now provide evidence that basement membranes are heterogeneous rather than homogeneous in composition. In addition, tissue-specific isoforms of the "prototype'' basement membrane components are now known to exist 40 1 (46), confirming previous speculation that basement membranes are indeed tissue-specific structures.
The concept of the basement membrane as a dynamic rather than a static structure is ultimately realized in organ and tissue development. In comparison to the homeostasis with regard to basement membrane biosynthesis/degradation seen in most adult tissues, tissue and/or organ morphogenesis is a rapidly progressive event that provides opportunities to study basement membrane functionality. Developmental biologists f m recognized that during morphogenesis tissue histoarchitectural boundaries undergo continuous remodeling and modification as structures form and expand. From the simplistic view of basement membranes as structural supports or boundaries, it is important to understand the processes by which basement membranes or their component molecules are produced, modified, or removed in temporally and spatially specific sequences to direct and accommodate proper tissue growth (21). Indeed, many classic studies have eloquently dissected and demonstrated these processes (7J2.22). but the molecular basis is unclear. On the basis of present knowledge, two different mechanisms could account for the formation of tissue-specific basement membranes. Either basement membranes are constructed as tissuespecific structures from the very onset of morphogenesis or there is a "generic" basement membrane structure common to many tissues, with eventual tissue-specific modifications made during subsequent maturation.
Renal development provides an opportunity to examine basement membrane formation because it allows simultaneous study of the genesis of several basement membranes that are known to differ in structural organization, composition, and function in the adult animal. Basement membrane formation during glomerular morphogenesis has been extensively studied (11,15-17,30-32,42, 43.48). Inductive events within the mesenchymal cells of the metanephros are initiated by the ureteric bud as it invades the presumptive renal mass. Induction triggers a well-defined temporal sequence of architectural organizational changes, described morphologically as vesicle, comma, and s-shaped stages, capillary loop stage, and maturing glomerulus stages (for review see 1,48). As a result of induction, a change in phenotype occurs: mesenchymal cells of the metanephros directly adjacent to the ureteric bud transform into epithelial cells. The phenotypic change is subsequently reflected in a change in expression from the interstitial type of matrix molecules to those found almost exclusively in basement membranes (15). From the common point of genesis at the vesicle stage, the developmental paths of the glomerular capillary basement membrane (GBM) and the basement membranes of Bowman's capsule and tubule basement membrane (TBM) diverge as the result of a second inductive event, the ingrowth of vasculature into the glomerular cleft in the comma stage. A third basement membranelike structure, the mesangial matrix, may also have its origins in the mesenchymal cells of the ingrowing vasculature at this time. However, the exact process of its formation is unclear.
Our laboratory recently reported the production of monoclonal antibodies that recognize the core protein d a newly described basement membrane-specific chondroitin sulfate proteoglycan (BM-CSPG) (38). The prototype BM-CSPG, initially isolated from Reichert's membrane (25, 38) , has been shown to possess a core protein, immunologically distinct from that of known BM-HSPGs, of approximately 150 KD bearing 13-22 glycosaminoglycan chains of each approximately 20 KD. Although the original antigen was isolated from an embryonic tissue source, we have also identified a similar proteoglycan in adult rat tissues (38). Our light microscopy immunohistochemistry studies indicated that BM-CSPG was present in almost every tissue. There was one notable exception-the normal adult GBM lacked BM-CSPG. Our results showed that in the adult glomerulus there was a specific compartmentalization of basement membrane proteoglyrans (38,39), with BM-HSPG present in both the GBM and mesangial matrix and BM-CSPG restricted to the mesangial matrix. These findings corroborated biochemical observations of glomerular proteoglycan composition reported in previous studies (26-28,50). The restricted distribution of BM-CSPG with respect to BM-HSPG suggested to us that at some point during glomerular development, structure-specific divergence of basement membrane composition must occur (35). The present study was undertaken to investigate the immunohistochemical distribution of BM-CSPG during kidney development.
Materials and Methods
Reagents and Antibodies. The characterization ofmonodonal antibodies (MAb) 2D6 and 2B5, which have been shown to recognize the core protein of a basement membrane-specific chondroitin sulfate proteoglycan (BM-CSPG) (38) and polyclonal antibodies that recognize the core protein of a basement membrane heparan sulfate proteoglycan (BM-HSPG) (U), laminin (4). and fibronectin has been reported previously. Non-immune mouse IgG was obtained commercially (Jackson hmunoresearch; West Grove, PA), as were fluorescein (FIIQconjugated goat anti-mouse IgG (no crossreactivity to rat) and rhodamine (TR1TC)-conjugated goat anti-rabbit IgG secondary antibodies (Organon Teknika-Cappel; Durham, NC). All chemicals, unless otherwise stated, were obtained from Sigma (St Louis, MO).
For immunoelectron microscopy studies, MAb 2D6 IgGl was affinitypurified from mouse ascites fluid using protein G-Fast Flow (Pharmacia; Piscataway, NJ) according to published methods (23). MAb purity was subsequently verified by SDS-PAGE. Horseradish peroxidase (HRP) was covalently coupled to MAb 2D6 IgGl or non-immune mouse IgG according to the method of Nakane et al. (41) . The resultant conjugate was dialyzed into PBS and concentrated to 1-2 mglml before injection into animals. Light Microscopy Studies. Animals used in the study were euthanized by ether overdose. Kidneys were removed from freshly euthanized animals, sliced transversely into three parts with a razor blade, and either snap-frozen in 2-methylbutane/acetone/solid CO2 as described previously (38, 39) or immediately immersed in acid alcohol for overnight fixation. Preliminary studies were performed on unfixed frozen tissue sections and fixed (see and 2B5 (39). The kidneys were processed for paraffin embedding, sectioning, and single-or double-label immunostaining as described previously (38.39). In some tissue sections cell nuclei were counterstained with Hoechst 33258 nuclear stain. Single and in-camera double-and triple-exposure micrographs of tissue sections were taken on Ektachrome-400 (KOdak; Rochester NY) or Ilford HP-5 (Mobberly, Cheshire, UK) films with a Nikon Optiphot microscope equipped for epifluorescence with rhodamine, fluorescein, and uv optics.
Electron Microscopy Studies. Kidneys from 3-, 7-, 21-, and 42-day-old rats (three animalslgroup) were examined by immunoelectron microscopy. Animals were anesthetized with ether and antibodylHRP conjugate in PBS was injected intravenously via the femoral vein. The wound was closed with surgical clips and the animals allowed to recover. After 4 hr the animals were re-anesthetized with ether, the abdominal cavity was opened, and the kidneys were injected with Karnovsky's fixative (29) in situ. The kidneys were then excised, the cortex separated from the medulla, and cortical pieces fixed for 2 hr in the same fixative. The tissue was rinsed three times for ten min with Sorensen's phosphate buffer, pH 7.4, with 3.5% sucrose and then histochemically processed for HRP (20) . The tissues were dehydrated through a graded series of alcohols (30-50-70-80-9>-100%) and propylene oxide, and embedded in EMBED-812 (Polysciences; Warrington, PA) according to the manufacturer's directions. Tissue sections were cut at 60-80 nm with a Nova Ultramicrotome (Cambridge Instruments; Buffalo, NY) equipped with a diamond knife (Diatome USA; Fort Washington, PA), collected on 200-mesh copper grids, and subsequently counterstained with lead citrate (44) . The tissue sections were examined and photographed with a Hitachi H-7000 transmission electron microscope.
Results

Prenatal Development and Nephrogenesis
Our initial studies focused on changes in distribution of extracellular matrix components in the kidney during the latter part of prenatal development (Days 18 and 20 of gestation). During prenatal (Days 18-21) and postnatal (Days 1-7) development, one is able to visualize all phases of nephron development in several transverse sections of the same kidney (48). During the latter prenatal phase, primitive nephron precursors (i.e., vesicle, comma, and s-stage SUUCtures) predominate over structures that resemble the architecture of adult glomeruli (i.e., capillary loop-stage glomeruli). We used laminin, fibronectin, and BM-HSPG antisera staining patterns to serve as a "benchmark" for comparison with immunostaining patterns observed for BM-CSPG.
BM-CSPG Is Emporady and Spatially Restricted During Nephrogenesis
Our initial observations on the immunostaining patterns of the former matrix components in fetal rats of Day 18 gestation corroborated those previously reported in the literature (3, 15, 16, 40) . Our studies showed, with few exceptions, that fibronectin, laminin, and BM-HSPG were present in the basement membranes associated with the capsule, ureteric buds, tubules, and vasculature already present in the kidney (Figure 1 ). Fibronectin-( Figure 1A ) and laminin (Figure lB)-associated immunostaining was also noted in the areas adjacent to mesenchymal condensates. We also noted that the BM-HSPG ( Figures 1C and 2A) immunostaining pattern of the ureteric bud was variable, depending on the region examined. BM-HSPG was present in the areas where the ureteric bud was already established (i.e., proximal portion) and in the cleft areas of the bud bifurcations. BM-HSPG-associated basement membrane immunostaining was weak beyond the bifurcation point in zones of active bud growth. With regard to glomerular morphogenesis, the former matrix components were first seen associated with vesiclestage mesenchymal condensations, the stage of glomerular development in which basement membranes are first found. This corresponds with the post-induction change in cell phenotype from mesenchymal cells to epithelial cells (15). For the remainder of nephrogenesis and growth these matrix components appeared to persist in the majority of the basement membranes.
BM-CSPG had a remarkably different staining pattern in the developing kidney when compared with the other basement membrane components ( Figure ID, cf. Figures lA-lC) , being both temporally and spatially restricted. Examination of single- (Figures 1C  and 1D ) and double-labeled (Figures 2A and 2B) sections showed that BM-CSPG co-distributed with BM-HSPG in the presumptive collecting ducts, ureteric bud cleft areas, established tubules, and the vasculature. However, BM-CSPG was notably absent from the basement membranes associated with vesicle-stage mesenchymal condensations and early comma-stage nephrons. We found BM-CSPG to be first present in the BM of late comma and early s-stage nephrons ( Figures 1D and 2B ). Between those classes of developing nephrons there was a distinct difference in the degree of BM-CSPG immunoreactivity, with the late comma-stage BM having a weaker immunoreactivity compared with the developmentally later s-stage figures ( Figure 2B ). In addition, there were regional differences within each stage with respect to the relative intensity of BM-CSPG and BM-HSPG hmunostaining. During both these stages of glomerular development, the vasculature has begun to invade and rarmfy within the cleft area, the site within which the glomerulus subsequently develops. The intensity of BM-CSPG-and BM-HSPGassociated immunofluorescence seemed greater in the cleft than in the other basement membranes present in the same figure. Similar observations about this cleft region have been made for other BM molecules (32) . However, in the case of BM-CSPG-associated immunofluorescence, this increased intensity of immunostaining within the glomerular cleft cells is associated with the cells of the invading vasculature ( Figure 3B , inset), its pattern of distribution being more pericellular in appearance.
Double-label studies with BM-CSPG and BM-HSPG antibodies revealed that the proteoglycan populations were segregated into apparently separate compartments in early capillary loop stage glomeruli of kidneys from Day 18 gestation fetal rats ( Figures  2C-2E ). BM-HSPG-associated immunofluorescence was relatively strong in the peripheral loop GBM, clearly delimiting this structure in all tissue sections examined ( Figure 2C ). In contrast, BM-CSPG appeared to be absent from the GBM but immunostained the mesangium intensely ( Figure 2D ).
Postnatal Glomerular Development, Maturation, and Growtb
The patterns of BM component distribution described were consistently reiterated during the postnatal phases ( Figure 3) . As in the prenatal kidney, BM-CSPG was first detected in basement membranes associated with the late comma-and early s-stage figures ( Figure 3B ). In subsequent stages of glomerular development (i.e., capillary loop-stage glomeruli), BM-CSPG and BM-HSPG were found in the mesangial matrix and Bowman's capsule as well as all tubular and vascular structures ( Figure 3 ) associated with those glomeruli. These structures were positive for both proteoglycans from this point in development through maturity. However, when tissue sections stained for both proteoglycans were compared, an apparent gradient with respect to the presence of BM-CSPG within the GBM of maturing capillary loop stage glomeruli was found, the outermost glomeruli having little to no BM-CSPG associated with the GBM, but an increase in GBM BM-CSPG staining was seen in the glomeruli located towards the juxtamedullary region. In this region we found what appeared to be co-localization of BM-CSPG ( Figure 3B , cf. Figure 4A ) with BM-HSPG (Figure 3A, cf. Figure 4B ) in the GBM of maturing-stage glomeruli. However, immunostained sections counterstained with Hoechst nuclear stain ( Figure 4C have been interpreted as capillaries cut in cross-section, were in fact cell bodies of presumptive mesangial cells (e.g., arrows in Figures  4A-4C ) surrounded circumferentially by a layer of matrix. Subsequent electron microscopy studies (see below) verified this observation.
The use of the in vivo labeling technique and immunoelectron microscopy corroborated in part our light microscopy observations, as intense BM-CSPG-associated HRP immunolabeling was found predominantly in the developing mesangial matrix of capillary loopstage glomeruli ( Figure 5 ). Some BM-CSPG staining was also seen in the GBM but was relatively sparse and discontinuous, with the greatest amount present in the GBM beneath portions of endothelial cells immediately adjacent to the mesangial matrix. In contrast, the mesangial matrices and capillary loops from animals injected with non-immune mouse IgG/HRP complex were completely negative (data not shown).
In double-label immunofluorescence studies of Day 7 postnatal rat kidneys, the maturing-stage glomeruli had increased in number, the majority of which appeared to have BM-CSPG and BM-HSPG co-distributed in the GBM (Figure 4D and 4E ). However, as previously mentioned, we found that the strongest co-localization for both proteoglycans appeared to be primarily associated around the circumference of the cells of the developing mesangium ( Figures  4D-4F, arrows) . Electron micrographs revealed that BM-CSPG was localized intensely to the mesangial matrix and in spots to the lamina rara interna and lamina densa of the GBM. Rather than the linear pattern of deposition indicated by the light micrographs ( Figures  4D-4F ), BM-CSPG had a patchy localization, as indicated by the presence of HRP reaction product ( Figure 6 ).
Discrete peripheral loop GBM immunoreactivity for BM-CSPG was most evident at 21 days after birth. Double-labeled sections counterstained with the Hoechst nuclear stain clearly showed BM-CSPG to be immunolocalized to the GBM (Figure 41 ) The mesangial matrix, as outlined by BM-CSPG staining, changed in appearance, going from the diffuse pericellular pattern seen on postnatal Day 7 ( Figure 4D ) to a more compact, arborized pattern resembling that of a mature glomerulus ( Figure 4G , 6. Figure 4J) (38,39) .
Ultrastructurally, BM-CSPG immunostaining of the GBM at this stage during development, although more intense than that seen at earlier ages, was still discontinuous, with areas of positive GBM immunoreactivity interspersed between negative regions ( Figure  7) . Many sites of newly synthesized GBM material, appearing as subepithelial outpockets, were frequently observed. BM-CSPG was not detected in this new material, which is thought to be primarily synthesized by podocytes (2), but was present in areas of existing basement membrane flanking the outpockets.
Double-label immunostaining of tissue sections of kidney taken from animals 42 days old indicated a transition between the above pattern of BM-proteoglycan distribution and that of the adult pattern of BM-proteoglycan distribution described previously (38,39). Glomeruli possessed three distinct immunostaining patterns: those with capillary loops exhibiting BM-CSPGIBM-HSPG co-distribution; glomeruli with some loops that possessed both BM-CSPG and BM-HSPG and some that possessed BM-HSPG only (arrows, Figures  4J-4L) ; and glomeruli with only BM-HSPG in the capillary loops. The fully mature glomerular capillary loops remained strongly positive for BM-HSPG, whereas the mesangial areas were intensely labeled for both BM-HSPG and BM-CSPG. Electron micrographs of glomeruli from 42-day-old rats showed capillary loops that were predominantly negative for BM-CSPG-associated immunostaining (Figure 8) . By 56 days after birth, all of the GBM were negative for BM-CSPG but the mesangial matrices remained positive.
Discussion
The results of our study show that BM-CSPG is both temporally and spatially regulated during nephrogenesis and is virtually absent in the earliest formed basement membrane associated with the vesicle-stage and early comma-stage structures. BM-CSPG was first found associated with basement membranes of late commastage structures after initial vascular invasion of the glomerular cleft. These findings are unlike that reported for any of the other basement membrane components during glomerular morphogenesis which, for the most part, are present as soon as basement membranes are formed. However, our studies also showed BM-CSPG to be transiently associated with the maturing glomerular capillary loop stage basement membranes, its presence in those membranes becoming most abundant at 3 weeks and persisting up to approximately 6 weeks after birth, after which time it appears to be removed.
BM-CSPG and Nephrogenesis
Basement membrane biogenesis in nephron development has been shown to encompass three processes: basement membrane secretion, "GBM fusion," and "splicing" (2). These three processes are thought to transpire as a result of cell/cell inductive interactions that occur during morphogenesis. Correspondingly, phenotypic alterations resulting from such interactions are in turn reflected in differences in the biochemical composition of the extracellular matrices of the interstitium and basement membrane. In the case of early basement membrane secretion, the biosynthesis of the primordial basement membranes of the vesicle stage nephron is initiated by the interaction of the ureteric bud with mesenchyme of the metanephros, catalyzing the transformation of the mesenchymal cells of the metanephros into epithelial cells. As a result of this phenotypic change, the induced cells change production of extracellular matrix from interstitial components (e.g., Types I and 111 collagen) to basement membrane components. In light of these previous findings, we predicted that the expression of BM-CSPG might follow a similar pattern of expression. Our results do show that the expression of BM-CSPG is also reflective of inductive interactions (see below), but its pattern of expression is especially unique as compared with those reported earlier for other matrix molecules (e.g., laminin, Type IV collagen, fibronectin) (15). Since BM-CSPG is not present in the earliest formed basement membranes, our findings imply that its presence may not be necessary for the initial assembly of primordial basement membranes. Moreover, its absence in the adult GBM also suggests that BM-CSPG is not absolutely necessary for maintenance of basement membrane structure in some tissues. The results strongly suggest that during initial development, basement membranes may be first assembled in a "generic" format with respect to composition and then modified to fit functional parameters possibly dictated by subsequent tissue-specific inductive interactions. The recent revelation that tissue-specific isoforms of basement membrane components (46) exist leads to the suggestion that such a developmental mechanism may occur in the acquisition of basement membrane diversity.
The fact that BM-CSPG is not expressed in the early inductive stages of nephrogenesis also suggests the possibility of an alternative inductive event that promotes the cellular expression of BM-CSPG. One possibility is that vascular invasion into the developing nephron encompasses a second inductive event affecting basement membrane biosynthesis. The glomerular capillaries are thought to arise as a result of the ingrowth of invading vascular tissue into the glomerular cleft of the comma-stage nephron (47). Kidney rudiments grown in short-term organ culture without the presence of invading vasculature show developmental figures resembling those seen in vivo ( 1 1). Moreover, the capillary loop-stage glomeruli present in those kidneys developing in vitro lacked both mesangium and juxtaglomerular apparatus, indicating that those particular structures are of vascular origin (11). In addition, the presence of vasculature in the cleft has been associated with an increase in the biosynthesis of matrix proteins in that area (32) . Our light micros-copy findings show that the invading vasculature possessed BM-CSPG before invasion into the developing nephron. BM-CSPGassociated immunofluorescence is weak in the early comma-stage nephron, where the glomerular cleft is first formed under the influence of the invading vasculature. In the later comma stagelearly s-stage, BM-CSPG-associated immunofluorescence increases in intensity in the glomerular cleft and the basement membranes of the parietal epithelium after vascular invasion has been completed. Although coincidental, we cannot entirely preclude the possibility that BM-CSPG biosynthesis in the developing nephron is initiated by local vascular ingrowth. The origin of BM-CSPG synthesized by the cells within the confines of the glomerular cleft is at present uncertain, but the fact that it is present in the lamina rara interna of the GBM of maturing capillary loop-stage glomeruli and mesangial matrix suggests that it is a product of mesangial and endothelial precursor cells derived from the invading vasculature. More likely than not, these cells maintain their ability to synthesize BM-CSPG during the latter stages of morphogenesis, with the endothelial cells ceasing BM-CSPG biosynthesis during functional specialization of the glomerulus that occurs during the latter stages of maturation.
The mechanism of removal of BM-CSPG from the GBM during glomerular maturation is also enigmatic. The results of several studies suggest that the podocytes are responsible for the production of the GBM (2) during the subsequent stage of capillary loop expansion, a process maintained into adulthood, albeit at a greatly reduced rate. It has been suggested that new basement membrane synthesized by the podocytes is added to the existing basement membrane by "splicing" (2) into the existing GBM, although the exact mechanism of "splicing" is uncertain. Our results show that outpocketings of newly synthesized basement membrane material found in the maturing glomerulus do not contain BM-CSPG, suggesting that after GBM fusion the podocytes do not make BM-CSPG. Therefore, the removal of BM-CSPG from the maturing peripheral loop GBM might occur as a result of normal biosynthetic turnover, i.e., the replacement of an immature, unspecialized basement membrane over time with the more specialized basement membrane of the adult GBM.
One explanation for progressive loss of BM-CSPG from the maturing GBM could be derived in part from our proposed function for BM-CSPG, chat it plays a role in maintenance of a structurally stable basement membrane (14, 19, 39) or is indicative of a stable basement membrane. Apart from many morphological studies showing the unique structure of the adult GBM from other renal basement membranes, the results of recent studies show an apparent dichotomy in the rate of turnover of glomerular proteoglycan populations (5). The normal adult GBM has been shown to have a rate of turnover for BM-HSPG with an estimated t 1 / 2 of 5-20 hr (5). This rapid turnover rate of BM-HSPG could be construed to be functionally correlative with earlier studies indicating that BM-HSPG serves as an active part of the filtration apparatus of the glomerulus (18), i.e., a filtration surface undergoing continuous renewal. The rate of turnover of the total glomerular galactosaminoglycan (chondroitin/dermatan) population, predominantly found in the mesangial matrix, was shown to be substantially longer ( 5 ) . When viewed from the perspective of the differential rate of turnover between the two proteoglycan populations, the GBM could be thought to be a relatively unstable structure, the instability a functional necessity. Therefore, the loss of BM-CSPG from the GBM could also be correlative with attainment of normal GBM function. Conversely, the presence of BM-CSPG in the GBM could signal an alteration from the normal dynamics of GBM biosynthesis, a premise supported by the results of ongoing studies which show BM-CSPG abnormally present in the GBM of diabetic rats, associated with areas of thickened GBM (36, 37) .
